1-145751506-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000582693.5(RNF115):c.505G>A(p.Gly169Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000971 in 1,442,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000097 ( 0 hom. )
Consequence
RNF115
ENST00000582693.5 missense
ENST00000582693.5 missense
Scores
3
2
2
Clinical Significance
Conservation
PhyloP100: 5.39
Genes affected
RNF115 (HGNC:18154): (ring finger protein 115) Enables ubiquitin-protein transferase activity. Involved in negative regulation of epidermal growth factor receptor signaling pathway; protein autoubiquitination; and ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.768
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF115 | NM_014455.4 | c.505G>A | p.Gly169Arg | missense_variant | 6/9 | ENST00000582693.5 | NP_055270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF115 | ENST00000582693.5 | c.505G>A | p.Gly169Arg | missense_variant | 6/9 | 1 | NM_014455.4 | ENSP00000463650.1 | ||
RNF115 | ENST00000539368.2 | n.2210G>A | non_coding_transcript_exon_variant | 3/6 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000893 AC: 2AN: 224066Hom.: 0 AF XY: 0.00000831 AC XY: 1AN XY: 120342
GnomAD3 exomes
AF:
AC:
2
AN:
224066
Hom.:
AF XY:
AC XY:
1
AN XY:
120342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000971 AC: 14AN: 1442222Hom.: 0 Cov.: 28 AF XY: 0.0000126 AC XY: 9AN XY: 715596
GnomAD4 exome
AF:
AC:
14
AN:
1442222
Hom.:
Cov.:
28
AF XY:
AC XY:
9
AN XY:
715596
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.505G>A (p.G169R) alteration is located in exon 6 (coding exon 6) of the RNF115 gene. This alteration results from a G to A substitution at nucleotide position 505, causing the glycine (G) at amino acid position 169 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
LIST_S2
Uncertain
D
MetaRNN
Pathogenic
D
Sift4G
Benign
T
Vest4
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at